OZEMPIC EFFECT
Beware of weight loss medications; they can make you go blind
A recent study conducted by researchers at Massachusetts Eye and Ear hospital has found a significant link between popular weight loss drugs containing semaglutide and an increased risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a rare condition causing sudden vision loss in one eye. The study, published in JAMA Ophthalmology, revealed that obese patients using these medications were over seven times more likely to develop NAION, while diabetic patients faced more than four times the risk.
Weekly-once insulin jab may soon come to India
A new weekly insulin dosage by Novo Nordisk, Insulin Icodec, is on the brink of approval in India, offering potential relief for those who require daily insulin injections. The Subject Expert Committee has recommended permitting the import and sale of this innovative product, expected to revolutionise the insulin market. While further studies are required, doctors anticipate improved patient compliance with this new treatment option.
Ozempic frenzy lures rich Indians to brave the gray market
People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying counterfeit formulas online, and importing boxes from Europe. The treatments have sparked extensive media coverage, fueling a high demand. According to Goldman Sachs Research, the anti-obesity medication market could hit $100 billion by 2030. In contrast, Indians have largely been observers in this global frenzy over the new weight-loss solutions.
New study warns of serious side effects from popular weight loss drugs Wegovy and Ozempic, finds they may paralyse stomach
A recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis, characterized by delayed stomach emptying. The study, presented at Digestive Disease Week 2024, indicates a 30% higher risk for users of these drugs. Experts emphasize the need for awareness and medical monitoring of potential gastrointestinal side effects.
Unlocking health benefits: Should you prioritize vegetables over carbs in your meals?
The debate over whether to eat vegetables before carbohydrates for better health revolves around the idea of meal sequencing and its impact on blood sugar levels. While some studies suggest that consuming vegetables first can lead to lower blood sugar spikes, especially for those with diabetes or pre-diabetes, experts note that the benefits may not be significant for everyone.
Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot
Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.
- Go To Page 1
Eli Lilly in advanced clinical trials for its weight-loss pill
Eli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess its safety and efficacy compared to insulin glargine in individuals with Type 2 diabetes and obesity or overweight at an increased cardiovascular risk. The company's spokesperson in India mentioned ongoing clinical studies on novel products, including orforglipron.
Eli Lilly could launch obesity drug in India next year, CEO says
Eli Lilly plans to launch its diabetes and obesity drug, Mounjaro, in India next year. The drug contains tirzepatide and is sold as Zepbound in the US. The global market for GLP-1 receptor agonists, including Mounjaro, Wegovy, and Ozempic, is expected to reach $100 billion by the end of the decade. Lilly's drugs as well as Danish rival Novo Nordisk's in-demand Wegovy and Ozempic are therapies known as GLP-1 receptor agonists, which were developed to control blood sugar in patients with type 2 diabetes.
Househelp on chhutti? Fret not, reader, here’s a survival guide to get through the torment
How can you look after your house, pets and yourself, and, on top of all that, try to earn a living when you’re left Robinson Crusoeing? Saying goodbye to fancy meals and saying hello to oranges could be a start.
Budget Ozempic: Know about this weight loss trend on Tik Tok and its associated risks
In recent years, Ozempic, the winning diabetic drug is very much in demand, taking the world of weight loss by storm. Here's everything to know more
Weight-loss drugs: Who, and what, are they good for?
The new drugs are known as GLP-1 agonists, which mimic the activity of a hormone that slows digestion and helps people feel full for longer. In clinical trials, people lost 15% to 20% of their body weight, depending on the drug. Nearly 120 million American adults could be eligible for treatment, while Novo says its target market is more than 760 million people with obesity worldwide.
Maker of Wegovy, Ozempic showers money on US obesity doctors
Novo Nordisk, a Danish pharmaceutical company renowned for its diabetes medicines, is now positioning itself as the world's leading weight-loss company. The company aims to target the global population of 764 million people with obesity, with the United States being its most lucrative market. In the U.S., where over two-thirds of adults are either overweight or obese, Novo charges customers $1,300 per month for the weekly injection of Wegovy.
Novo Nordisk, maker of Ozempic and Wegovy sues two pharmacies for ‘selling impure drugs’
Over alleged selling of contaminated drugs, two Florida-based pharmacies have been sued by Novo Nordisk. The company claims that the substance used for the production of the drugs does not have approval from the FDA.
What is Ozempic? Exploring Hollywood's viral obsession and its weight loss appeal
Hollywood’s caught onto Ozempic! Initially for Type 2 diabetes, the FDA-approved drug, semaglutide (marketed as Ozempic), has become a celeb-driven weight loss trend. Amid shortages and denials, stars like Amy Schumer openly discuss its effects. Concerns arise about "Ozempic face" – facial sagging due to rapid weight loss. Stars have mixed thoughts – cautionary or critical – sparking a debate on bodies and fame's influence.
How well-off Brits still buy Ozempic online for weight loss
The demand for the diabetes drug Ozempic, known for its weight-loss effects, has led to shortages in countries like Britain and the United States. A contrast in access reveals that those with means can purchase it online for weight loss, despite government restrictions. The shortage, caused by overwhelming demand, is impacting diabetes patients dependent on the NHS, jeopardizing their health.
Is Sharon Osbourne’s dramatic weight loss of 100 Pounds due to Ozempic? TV star reveals the truth
Renowned TV personality and podcast host Sharon Osbourne openly discussed her weight-loss journey, crediting the drug Ozempic for her notable transformation. While acknowledging the popularity of celebrities utilizing the drug for weight management, Osbourne also cautioned potential users.
Headline: 5 Actors Who Have Openly Talked about Taking Ozempic for Weight Loss
Hollywood actors are weighing on with their opinions on the weight-loss drug Ozempic and questioning the craze for getting thinner.
Fake weight loss injections leave people in comas, urgent safety alert issued
Fake weight loss injections, falsely marketed as Ozempic or Saxenda, have triggered significant safety alarms in the United Kingdom. Authorities are cautioning the public about the substantial risks associated with these counterfeit products, as several individuals have encountered life-threatening medical complications.
Fake Ozempic pens circulating in Europe, watchdogs warn
Counterfeit injection pens falsely labeled as Ozempic, a popular diabetes drug also used for weight loss, have been discovered in Europe, according to drug authorities. The fake pens originated from wholesalers in Austria and Germany, and found at some wholesalers in the EU and UK.
Corporate America weighs risks of the Ozempic effect
U.S. companies in various sectors, including food and beverage, medical devices, and dialysis services, are facing questions from investors regarding the impact of weight-loss drugs on their future sales. Companies like Conagra and Walmart are considering potential changes in portion sizes and expect increased revenues from health and wellness products due to the popularity of these drugs. On the other hand, companies like PepsiCo and Abbott Laboratories do not anticipate a significant impact on their sales.
Nestlé responds to weight-loss drug surge: Developing health aids for Ozempic, Wegovy users
Nestlé, the global food leader, is responding to the growing trend of appetite-suppressing weight-loss medications like Ozempic, Wegovy, and Mounjaro by innovating complementary products. These pharmaceutical advancements have prompted considerations regarding their potential influence on food sales and the financial performance of the food industry.
Dr Reddy's gears up for weight loss drug study
Dr Reddy's Laboratories has received approval from India's drug regulatory authority to conduct a bioequivalence study for the weight loss drug Semaglutide. The company had sought a waiver for the study and a Phase III clinical trial, but the SEC recommended conducting the study. If all goes well, the drug could be launched within a year.
Hollywood's blockbuster weight loss drugs are becoming all the rage among affluent Indians
According to doctors and fitness experts, queries come in every other day from (well-heeled) patients, asking whether they can take the expensive, injectable drugs to shed those stubborn kilos. “It’s coming up in conversations everywhere. Patients ask me about it all the time,” says Ambrish Mithal, chairman and head of endocrinology, Max Healthcare. There are a lot of people interested in taking Ozempic because “the weight loss is so dramatic”, says Kiran Sethi, medical director, Isya Aesthetics.
Budget Ozempic: Can this laxative be the answer to all of your weight loss woes?
These are drugs normally used as laxatives and stool softeners, but people are taking them to lose weight.
Doctor-approved or internet-brewed? Exploring lesser known health fads of 2023
A list of wellness trends for 2023 include the use of Ozempic and similar drugs to suppress appetite and reduce food noise, the resurgence of bathhouses and saunas for supposed health benefits, the popularity of supplements for better sleep, focus, stress, and boosting the immune system, the intertwined concepts of therapy and dating, and the continued craze over protein in various forms.
Can't afford Ozempic? Get to know about this organic weight loss alternative
Known as 'nature's own Ozempic' berberine can be a good choice for losing weight.
Berberine: All about the controversial dietary supplement hyped for weight loss by social media users
Berberine has become popular on social media as users have claimed that it aids in weight loss. Here are all the details related to Berberine which is now being used as a supplement for weight loss.
Too broke to afford Ozempic? From avocados to nuts, 5 foods to make you feel full & help you lose weight
The right diet can help you lose weight and provide nutritional support.
Blood sugar spikes, rapid heartbeats, diarrhoea: Learn 6 six effects of dropping Ozempic, the weight-loss ‘miracle’ drug
What happens if you stop taking Ozempic?
Load More
